【藥品訊息】 Xylocaine 苦息樂卡因凝膠 中文仿單

局部麻醉 Prevention and control of pain in procedures involving the male and female urethra; for topical treatment of painful urethritis

Blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction.

Sensitivity to local anesthetics of the amide type or to any other component of the product

B (FDA)

Compatible with breastfeeding (WHO)
Infant risk is minimal (MDX)

Edema, Erythema, Petechiae, Pruritus, Headache, Burning sensation in eye, Conjunctival hyperemia, Corneal epithelial defect

Anesthesia of male urethra: 5 to 30 mL (100 to 600 mg)
Anesthesia of female urethra: 3 to 5 mL (60 to 100 mg)
Maximum dose: 30 mL (600 mg) in any 12-hour period.

Dose varies with age and weight (maximum dose: 4.5 mg/kg)

There are no dosage adjustments provided in the manufacturer's labeling.

There are no dosage adjustments provided in the manufacturer's labeling; use caution in patients with severe hepatic disease.